Wal-Mart stocks EC
This article was originally published in The Tan Sheet
Executive Summary
Barr Labs' emergency contraceptive Plan B will be sold in Wal-Mart pharmacies nationwide effective March 20, the mass retailer announces March 3. Wal-Mart was required to sell the drug in Massachusetts following a ruling by the state's Pharmacy Board Feb. 14 (1"The Tan Sheet" Feb. 20, 2005, p. 5). The firm is also required to sell Plan B in Illinois, and states that "pressure to introduce similar mandates is building in Connecticut and New York." The likelihood of more states following suit and "the fact that this is an FDA-approved product" swayed the company, according to VP-Pharmacy Ron Chomiuk. "We feel it is difficult to justify being the country's only major pharmacy chain not selling" the drug, he stated. Wal-Mart will "maintain its conscientious objection policy," allowing pharmacists to refer consumers to other pharmacies if they object to filling the prescription...
You may also be interested in...
Wal-Mart Will Sell Plan B In Massachusetts; More States To Follow?
Wal-Mart has started stocking its pharmacies in Massachusetts with Barr Labs' Plan B emergency contraceptive following a Feb. 14 ruling by the state's Pharmacy Board
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.